ClinicalTrials.gg
TerminatedNCT01218087Updated Feb 3, 2017Results posted

Cranial Cup Use for the Prevention of Positional Head Shape Deformity in the NICU

An interventional study of Cranial cup device and Moldable positioner and Moldable positioner device in Plagiocephaly, Scaphocephaly and Brachycephaly, sponsored by Boston Children's Hospital. Terminated at 1 site in United States. Open to participants aged Up to 10 Days. Per ClinicalTrials.gov, last updated 2017-02-03.

Sponsored by Boston Children's Hospital · Not applicable, Interventional, and Prevention

Why this study was terminated
Study discontinued by DSMB due to loss of equipoise.
Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Randomized
Ages
Up to 10 Days
Sex
All
01

Study summary

Many hospitalized infants can develop a flattening of the back or sides of their head. This condition develops gradually when an infant's head rests on a firm or semi-firm surface for a prolonged period of time. Premature infants are more likely to have a positional head shape deformity because they may spend longer periods of time in a crib. Infants participating in this study will be randomly assigned to either standard treatment, which is a moldable positioner device, or to a cranial cup device and moldable positioner for positioning. The purpose of this prospective single-blinded randomized clinical trial will be to evaluate the effectiveness of the cranial cup in preventing positional head shape deformity in the NICU patient population.

Read the detailed description

The primary outcome for this study will be cranial index and cranial symmetry measured at hospital discharge; the secondary outcome measure is the incidence of oxygen desaturation events (apnea, bradycardia and oxygen desaturation).

The pilot study was undertaken to evaluate if the cranial cup can be successfully incorporated into the NICU patient care regime, the pilot study included 5 infants.

The main trial enrollment was estimated to be 160 infants from 4 centers. Upon enrollment infants will be randomized to one of two study groups

  • Cranial cup and moldable positioner
  • Moldable positioner

Inclusion criteria:

There are several inclusion criteria for participation in the study:

  1. Infants born at >/= 22 weeks gestation
  2. Infant that are \</= 7 days of age
  3. Infants that receive medical clearance from their healthcare team
  4. Infants that have an estimated minimum NICU length of stay = / > 14 days from the time of enrollment

Infants were stratified by study site and weight at enrollment (\< 1000 grams versus = / > 1000 grams).

02

Conditions studied

  • Plagiocephaly
  • Scaphocephaly
  • Brachycephaly

Keywords

  • Positional Head Shape Deformity
03

In context

Plagiocephaly

16 studies on the registry are indexed under Plagiocephaly; 4 are open to participants now.

Browse Plagiocephaly studies →

Lead sponsor

Boston Children's Hospital is the lead sponsor of 608 studies on the registry; 147 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 10 Days
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Infants born at >/= 22 weeks gestation
  2. Infant that are \</= 7 days of age
  3. Infants that receive medical clearance from their healthcare team
  4. Infants that have an estimated minimum NICU length of stay = / > 14 days from the time of enrollment

Exclusion criteria

Exclusion Criteria:

  1. Infants that require only prone positioning to maintain airway patency (such as those with Pierre Robin Syndrome/Sequence) will not be eligible to participate; this is because infants must be able to lie supine for at least part of the day to use the cranial cup
  2. Infants requiring medical devices such as a continuous ventricular drain, subgaleal shunt, or intravenous catheters (unless placement of the IV is temporary) prevent proper positioning using the cranial cup
  3. Infants with a craniofacial anomaly, cervical anomaly, or critical airway infants
  4. Infants with Cutis Aplasia or significant skin breakdown to the scalp, because the cranial cup may worsen a preexisting condition
  5. Infants with a prenatal diagnosis of craniosynostosis
  6. Infants deemed not suitable for participation by the attending neonatologist
  7. Infants that are to be transferred to a non-participating hospital within 14 days of enrollment as this timeframe may not be adequate to show a difference in head shapes
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
88 participants (actual)

Study arms

  • Experimental
    Cranial cup device and Moldable positioner device

    The cranial cup for 12/24 hours and the moldable positioner device was used for positioning infants the remainder of the 24 hours

    Device: Cranial cup device and Moldable positioner · Device: Moldable positioner device

  • Active comparator
    Moldable positioner device

    Moldable positioner device was used for positioning infants for 24/24 hours

    Device: Moldable positioner device

Interventions

  • DeviceCranial cup device and Moldable positioner

    The cranial cup device was used 12/24 hours (alternating with the moldable positioner device) and was evaluated for feasibility, safety and efficacy for preventing head shape deformity in hospitalized infants

  • DeviceMoldable positioner device

    This moldable positioning device was used 24/24 hours as a comparison to the cranial cup device.

06

What researchers measure

Primary outcomes

  1. Cranial Abnormalities Were Measured at Hospital Discharge

    Cranial abnormality measurements were obtained at hospital discharge by orthotists blinded to the study group assignment. Cranial abnormalities include both cranial index measures and cranial symmetry measures. Cranial index (normal measurement between 73%-85%) was obtained dividing the head width (M-L) by length (A-P) then multiplying it by 100%. Cranial symmetry (normal measurement of\<8mm) was obtained by calculating the difference in the right and left anterior-posterior measures.

    Time frame: up to 120 days

Secondary outcomes

  1. Incidence of Cardiorespiratory

    daily log of cardiorespiratory events (apnea, bradycardia, oxygen desaturation) collected on a daily positioning log at the infant's bedside

    Time frame: daily up to 120 days

07

Results

Posted Aug 26, 2015
Limitations and caveats
During the second interim analysis, safety monitors recommended early closure due to loss of study equipoise. Clinical staff had been reporting observable differences in infant head shapes for the two study groups.

Participant flow

Participant flow — Overall Study
MilestoneCranial Cup DeviceMoldable Positioner Device
Started4241
Completed2735
Not completed156
Withdrew: Death21
Withdrew: Withdrawal by subject50
Withdrew: Transferred85

Outcome measures

PrimaryCranial Abnormalities Were Measured at Hospital Discharge

Cranial abnormality measurements were obtained at hospital discharge by orthotists blinded to the study group assignment. Cranial abnormalities include both cranial index measures and cranial symmetry measures. Cranial index (normal measurement between 73%-85%) was obtained dividing the head width (M-L) by length (A-P) then multiplying it by 100%. Cranial symmetry (normal measurement of\<8mm) was obtained by calculating the difference in the right and left anterior-posterior measures.

Time frame:
up to 120 days
Reported as:
Number · % participant cranial abnormalities
Cranial Abnormalities Were Measured at Hospital Discharge
% participant cranial abnormalitiesCranial Cup DeviceMoldable Positioner Device
Cranial Abnormalities Were Measured at Hospital Discharge4619
Statistical analysis
  • Cranial Cup Device vs Moldable Positioner Device · Fisher Exact · p = 0.03
SecondaryIncidence of Cardiorespiratory

daily log of cardiorespiratory events (apnea, bradycardia, oxygen desaturation) collected on a daily positioning log at the infant's bedside

Time frame:
daily up to 120 days
Reported as:
Number · cardioresp. events/100hrs of device use
Incidence of Cardiorespiratory
cardioresp. events/100hrs of device useCranial Cup DeviceMoldable Positioner Device
Incidence of Cardiorespiratory5.45.9

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Cranial Cup Device—0/27 (0%)0/27 (0%)
Moldable Positioner Device—0/35 (0%)0/35 (0%)

Baseline characteristics

Approximately 800 infants from the 4 participating NICUs were screened; most were excluded for an anticipated length of stay of \< 14 days, for medical reasons, and a few parents declined. The total number enrolled out of the approximately 800 screened was 88.

Age, Continuous
Age, Continuous(days)Cranial Cup DeviceMoldable Positioner DeviceTotal
Median0 (0 to 7)0 (0 to 12)0 (0 to 12)
Gender
Gender(Participants)Cranial Cup DeviceMoldable Positioner DeviceTotal
Female91322
Male182240
Race/Ethnicity, Customized
Race/Ethnicity, Customized(participants)Cranial Cup DeviceMoldable Positioner DeviceTotal
White152641
African American7714
Asian101
Native Hawaiian011
Hispanic415
Region of Enrollment
Region of Enrollment(participants)Cranial Cup DeviceMoldable Positioner DeviceTotal
United States273562
08

Study locations

1 site
  • Children's Hospital Boston
    Boston, Massachusetts 02115, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01218087
Collaborators
Boston Orthotics & Prosthetics
Responsible party
Michele DeGrazia (Director Nursing Research, NICU, Boston Children's Hospital) — Principal investigator
First posted
Oct 11, 2010
Start date
Apr 2010
Primary completion
Jul 2012
Completion
Jul 2012
Results posted
Aug 26, 2015
Last update
Feb 3, 2017

Study contacts

Michele DeGrazia, PhD, NNP
principal investigator · Boston Children's Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion